関連する実験動画
Updated: Jun 7, 2026

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
転移性臓がんにおけるゲノム不安定性のパターンとダイナミクス
Peter J Campbell1, Shinichi Yachida, Laura J Mudie
1Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Nature
|October 29, 2010
まとめ
臓がんはゲノム再編成を早期に発達させ,遺伝子増幅と転移を促します. ゲノム不安定は,多様な転移部位における進行中の並列進化を助長する.
科学分野:
- ゲノミクスゲノミクスとは
- 癌生物学 癌生物学について
- 進化生物学の進化生物学について
背景:
- 臓がんは,主に転移による高い死亡率 (97-98%) を有しています.
- ゲノム環境は複雑で,コピー番号の変更や点変異が知られているが,ゲノム再編成はほとんど理解されていない.
- 転移性臓腫瘍のクローン構造,進化,拡散に関する根本的な疑問が残っています.
研究 の 目的:
- 臓がんにおけるゲノム再編成を注釈するために.
- 転移の間のクローン関係を調査する.
- 臓がんの転移の進化的動態を理解するために.
主な方法:
- 13人の臓がん患者のDNAシーケンス解析.
- ゲノム再編成の解説. ゲノム再編成について.
- 転移の間のクローン構造と系統学的関係の分析.
主要な成果:
- 臓がんは,テロメア機能不全と細胞サイクル制御 (G1-S不調) に関する再編成を取得します.
- これらの再編成は,腫瘍発達の初期に癌遺伝子の増幅を開始します.
- ゲノム不安定性は,拡散後も持続し,転移の並列で収束する進化につながります.
- 証拠は,転移を誘発する細胞と臓器特異の転移性分岐の異質性を示唆しています.
結論:
- ゲノムの再編成は,早期の臓がん発症と遺伝子増幅において重要な役割を果たします.
- 進行中のゲノム不安定は,転移の間の重要な進化的多様化を促しています.
- 転移のシードには追加のドライバ変異が必要であり,転移の進化は器官特異的です.
関連する概念動画
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

